EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Using inverse probability of censoring weighting to estimate hypothetical estimands in clinical trials: Should we implement stabilisation, and if so how?

Jingyi Xuan iD, Shahrul Mt-Isa, Nicholas R Latimer iD, Helen Bell Gorrod iD, William Malbecq iD, Kristel Vandormael, Victoria Yorke-Edwards iD, Ian R White

Statistical Methods in Medical Research · 2026-01 · 35 (1) · 40-60

DOI: 10.1177/09622802251387456 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistical Methods in Medical Research, online erschienen am 31.10.2025. Verfasst von Jingyi Xuan und 7 weiteren Autor:innen. Beteiligte Einrichtung: MRC Clinical Trials Unit at UCL, University College London, London, UK. Hauptthemen laut MEDLINE: Clinical Trials as Topic, Randomized Controlled Trials as Topic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council Programm, Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, Yorkshire Cancer Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inverse probability of censoring weighting is an approach used to estimate the hypothetical treatment effect that would have been observed in a clinical trial if certain intercurrent events had not occurred. Despite the unbiased estimates obtained by inverse probability of censoring weighting when its key assumptions are satisfied, large standard errors and wide confidence intervals can be potential concerns. Inverse probability of censoring weighting with unstabilised weights can be simply implemented by calculating the reciprocal of the probability of being uncensored by the intercurrent events. To improve precision, stabilisation can be realised by replacing the numerator in the unstabilised weights with functions of the time and baseline covariates. Here, we aim to investigate whether stabilised weight is a preferred choice and if so how we should specify the numerator. In a simulation study, we assessed the performance of inverse probability of censoring weighting implementations with unstabilised weights and with different forms of stabilisation when the outcome analysis model was correctly specified or mis-specified. Scenarios were designed to vary the prevalence of the intercurrent event in one or both randomised arms, the existence of a deterministic intercurrent event, the indirect effect through baseline covariates and overall treatment effect, the existence and the pattern of time-varying effect and sample size. Results show that compared with unstabilised weights, stabilisation improves the efficiency of the inverse probability of censoring weighting estimator in most cases and the improvement is obvious when we stabilise for the baseline covariates. However, stabilisation risks increasing the bias when the outcome analysis model is mis-specified.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials as TopicRandomized Controlled Trials as TopicHumansProbabilityModels, StatisticalComputer SimulationData Interpretation, Statistical

Stichwörter der Autor:innen

Inverse probability of censoring weightdependent censoringnon-adherencepropensity scorestabilisationtreatment switching

Autor:innen und Institutionen

  • MRC Clinical Trials Unit at UCL, University College London, London, UK.
  • Department of Infectious Disease Epidemiology and International Health, London School of Hygiene and Tropical Medicine, London, UK.
  • Biostatistics and Research Decision Sciences (BARDS) Health Technology Assessment (HTA) Statistics, MSD, Zurich, Switzerland.
  • Sheffield Centre for Health and Related Research, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.
  • Delta Hat Limited, Nottingham, UK.
  • Department of Mathematics, University of Brussels, Brussels, Belgium.

ORCID-Profile: Jingyi Xuan, Nicholas R Latimer, Helen Bell Gorrod, William Malbecq, Victoria Yorke-Edwards

Förderung

  • Medical Research Council Programm
  • Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA
  • Yorkshire Cancer Research
  • Medical Research Council Programme

Zitieren

APA

Xuan, J., Mt-Isa, S., Latimer, N. R., Bell Gorrod, H., Malbecq, W., Vandormael, K., Yorke-Edwards, V., & White, I. R. (2026). Using inverse probability of censoring weighting to estimate hypothetical estimands in clinical trials: Should we implement stabilisation, and if so how?. Statistical Methods in Medical Research, 35(1), 40-60. https://doi.org/10.1177/09622802251387456

Vancouver

Xuan J, Mt-Isa S, Latimer NR, Bell Gorrod H, Malbecq W, Vandormael K, et al. Using inverse probability of censoring weighting to estimate hypothetical estimands in clinical trials: Should we implement stabilisation, and if so how?. Statistical Methods in Medical Research. 2026;35(1):40-60. doi:10.1177/09622802251387456

BibTeX
@article{Xuan2026,
  author = {Xuan, Jingyi and Mt-Isa, Shahrul and Latimer, Nicholas R and Bell Gorrod, Helen and Malbecq, William and Vandormael, Kristel and Yorke-Edwards, Victoria and White, Ian R},
  title = {Using inverse probability of censoring weighting to estimate hypothetical estimands in clinical trials: Should we implement stabilisation, and if so how?},
  journal = {Statistical Methods in Medical Research},
  year = {2026},
  volume = {35},
  number = {1},
  pages = {40--60},
  doi = {10.1177/09622802251387456}
}
Kostenlos starten →